Coronavirus information

Information on the coronavirus pandemic for our patients and visitors.

View coronavirus information

Browse site A – Z

Your views

Your Views

Your feedback is vital to us as we continue to increase the quality of our services.

Your views

You are here:

Date: 26 May 2020

Time: 07:09

Patients discharged on anti-platelet therapy indicator

Percentage of patients discharged on anti-platelet therapy

How is the Trust doing?

Your browser does not support this graph; however, you can still view the statistics in the table below.

Rolling year to date (February 2019 – January 2020) 100%
Rolling 3 years (February 2017 – January 2020) 99.9%

Higher percentage indicates better performance.

The percentage of first-time, isolated CABG patients who are given anti-platelet therapy on the day of discharge remains steady over time

Why is this indicator important?

Anti-platelet drug therapy improves graft function through the prevention of clot formation for patients who have had a first-time, isolated CABG. It also helps prevent further cardiac problems.

The aim is for all eligible patients (patients for whom these drugs are suitable) to receive them on the day of discharge.

How do we measure this indicator?

The percentage of all patients admitted for first-time, isolated CABG given anti-platelet therapy (aspirin or clopidogrel) on the day of discharge.

Related pages

Getting Here

Getting here

Information about travelling to, staying at and getting around the hospital.

Getting to the hospital

Jobs at UHB

Jobs at UHB

A great place to work. Learn why.

Jobs at UHB

We're improving the accessibility of our websites. If you can't access any content or if you would like to request information in another format, please view our accessibility statement.